Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.
Schiller JH, Adak S, Feins RH, Keller SM, Fry WA, Livingston RB, Hammond ME, Wolf B, Sabatini L, Jett J, Kohman L, Johnson DH. Schiller JH, et al. Among authors: fry wa. J Clin Oncol. 2001 Jan 15;19(2):448-57. doi: 10.1200/JCO.2001.19.2.448. J Clin Oncol. 2001. PMID: 11208838 Clinical Trial.
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.
Albain KS, Swann RS, Rusch VW, Turrisi AT 3rd, Shepherd FA, Smith C, Chen Y, Livingston RB, Feins RH, Gandara DR, Fry WA, Darling G, Johnson DH, Green MR, Miller RC, Ley J, Sause WT, Cox JD. Albain KS, et al. Among authors: fry wa. Lancet. 2009 Aug 1;374(9687):379-86. doi: 10.1016/S0140-6736(09)60737-6. Epub 2009 Jul 24. Lancet. 2009. PMID: 19632716 Free PMC article. Clinical Trial.
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.
Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, Cormier Y, Goss G, Inculet R, Vallieres E, Fry W, Bethune D, Ayoub J, Ding K, Seymour L, Graham B, Tsao MS, Gandara D, Kesler K, Demmy T, Shepherd F; National Cancer Institute of Canada Clinical Trials Group; National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators. Winton T, et al. N Engl J Med. 2005 Jun 23;352(25):2589-97. doi: 10.1056/NEJMoa043623. N Engl J Med. 2005. PMID: 15972865 Free article. Clinical Trial.
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.
Lippman SM, Lee JJ, Karp DD, Vokes EE, Benner SE, Goodman GE, Khuri FR, Marks R, Winn RJ, Fry W, Graziano SL, Gandara DR, Okawara G, Woodhouse CL, Williams B, Perez C, Kim HW, Lotan R, Roth JA, Hong WK. Lippman SM, et al. J Natl Cancer Inst. 2001 Apr 18;93(8):605-18. doi: 10.1093/jnci/93.8.605. J Natl Cancer Inst. 2001. PMID: 11309437 Clinical Trial.
Malignant bone tumors of the chest wall.
Liptay MJ, Fry WA. Liptay MJ, et al. Among authors: fry wa. Semin Thorac Cardiovasc Surg. 1999 Jul;11(3):278-84. doi: 10.1016/s1043-0679(99)70069-9. Semin Thorac Cardiovasc Surg. 1999. PMID: 10451260
The National Cancer Data Base report on lung cancer.
Fry WA, Menck HR, Winchester DP. Fry WA, et al. Cancer. 1996 May 1;77(9):1947-55. doi: 10.1002/(SICI)1097-0142(19960501)77:9<1947::AID-CNCR27>3.0.CO;2-Z. Cancer. 1996. PMID: 8646697
67 results